{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:08:51Z","timestamp":1747901331497,"version":"3.40.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10067-020-04978-9","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T05:03:58Z","timestamp":1583557438000},"page":"1997-2001","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Primary antiphospholipid syndrome, Addison disease, and adrenal incidentaloma"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5891-8653","authenticated-orcid":false,"given":"Gabriela","family":"Medina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8958-1750","authenticated-orcid":false,"given":"Mar\u00eda Pilar","family":"Jim\u00e9nez-Arellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Mu\u00f1oz-Sol\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick","family":"Serv\u00edn-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Ram\u00edrez-Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-593X","authenticated-orcid":false,"given":"Luis J.","family":"Jara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,7]]},"reference":[{"issue":"Suppl 1","key":"4978_CR1","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","volume":"151","author":"R Cervera","year":"2017","unstructured":"Cervera R (2017) Antiphospholipid syndrome. Thromb Res 151(Suppl 1):S43\u2013S47. https:\/\/doi.org\/10.1016\/S0049-3848(17)30066-X","journal-title":"Thromb Res"},{"key":"4978_CR2","doi-asserted-by":"publisher","first-page":"161497","DOI":"10.1155\/2015\/161497","volume":"2015","author":"M Sahin","year":"2015","unstructured":"Sahin M, Oguz A, Tuzun D, Boysan SN, Mese B, Sahin H, Gul K (2015) Primary adrenal failure due to antiphospholipid syndrome. Case Rep Endocrinol 2015:161497. https:\/\/doi.org\/10.1155\/2015\/161497","journal-title":"Case Rep Endocrinol"},{"key":"4978_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1177\/0961203309106832","volume":"18","author":"R Cervera","year":"2009","unstructured":"Cervera R, Boffa MC, Khamashta MA, Hughes GR (2009) The Euro-Phospholipid Project: epidemiology of the antiphospholipid syndrome in Europe. Lupus 18:889\u2013893. https:\/\/doi.org\/10.1177\/0961203309106832","journal-title":"Lupus"},{"key":"4978_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1191\/0961203303lu404oa","volume":"12","author":"G Espinosa","year":"2003","unstructured":"Espinosa G, Cervera R, Font J, Asherson RA (2003) Adrenal involvement in the antiphospholipid syndrome. Lupus 12:569\u2013572. https:\/\/doi.org\/10.1191\/0961203303lu404oa","journal-title":"Lupus"},{"key":"4978_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/00005792-200303000-00005","volume":"82","author":"G Espinosa","year":"2003","unstructured":"Espinosa G, Santos E, Cervera R, Piette JC, de la Red G, Gil V, Font J, Couch R, Ingelmo M, Asherson RA (2003) Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Baltimore) 82:106\u2013118. https:\/\/doi.org\/10.1097\/00005792-200303000-00005","journal-title":"Medicine (Baltimore)"},{"key":"4978_CR6","doi-asserted-by":"publisher","unstructured":"Oliveira D, Ventura M, Melo M, Paiva S, Carrilho F (2018, 2018) Addison\u2019s disease in antiphospholipid syndrome: a rare complication. Endocrinol Diabetes Metab Case Rep. https:\/\/doi.org\/10.1530\/EDM-18-0118","DOI":"10.1530\/EDM-18-0118"},{"key":"4978_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1191\/0961203306lu2318rr","volume":"15","author":"I Uthman","year":"2006","unstructured":"Uthman I, Salti I, Khamashta M (2006) Endocrinologic manifestations of the antiphospholipid syndrome. Lupus 15:485\u2013489. https:\/\/doi.org\/10.1191\/0961203306lu2318rr","journal-title":"Lupus"},{"issue":"Suppl 1","key":"4978_CR8","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.4103\/2230-8210.119584","volume":"17","author":"KK Behera","year":"2013","unstructured":"Behera KK, Kapoor N, Seshadri MS, Rajaratnam S (2013) Acute adrenal insufficiency due to primary antiphospholipid antibody syndrome. Indian J Endocrinol Metab 17(Suppl 1):S240\u2013S242. https:\/\/doi.org\/10.4103\/2230-8210.119584","journal-title":"Indian J Endocrinol Metab"},{"key":"4978_CR9","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.path.2015.07.005","volume":"8","author":"A Pinto","year":"2015","unstructured":"Pinto A, Barletta JA (2015) Adrenal tumors in adults. Surg Pathol Clin 8:725\u2013749. https:\/\/doi.org\/10.1016\/j.path.2015.07.005","journal-title":"Surg Pathol Clin"},{"key":"4978_CR10","doi-asserted-by":"publisher","first-page":"830814","DOI":"10.1155\/2015\/830814","volume":"2015","author":"IN Khan","year":"2015","unstructured":"Khan IN, Adlan MA, Stechman MJ, Premawardhana LD (2015) A retroperitoneal leiomyosarcoma presenting as an adrenal incidentaloma in a subject on warfarin. Case Rep Endocrinol 2015:830814. https:\/\/doi.org\/10.1155\/2015\/830814","journal-title":"Case Rep Endocrinol"},{"key":"4978_CR11","doi-asserted-by":"publisher","first-page":"379852","DOI":"10.1155\/2013\/379852","volume":"2013","author":"S Kannan","year":"2013","unstructured":"Kannan S, Satra A, Hamrahian A (2013) Incidental lipid poor adrenal mass in a patient with antiphospholipid syndrome. Case Rep Endocrinol 2013:379852. https:\/\/doi.org\/10.1155\/2013\/379852","journal-title":"Case Rep Endocrinol"},{"key":"4978_CR12","first-page":"1020","volume":"3","author":"C Marinelli","year":"2015","unstructured":"Marinelli C, Petramala L, Iannucci G et al (2015) Resistant arterial hypertension in a patient with adrenal incidentaloma multiple steno-obstructive vascular lesions and antiphospholipid syndrome. Ann Clin Exp Hypertens 3:1020","journal-title":"Ann Clin Exp Hypertens"},{"key":"4978_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/17446651.2016.1233055","volume":"11","author":"I Mackay","year":"2016","unstructured":"Mackay I, Aspinall S (2016) Advances in our understanding of the prognosis of adrenal incidentaloma. Expert Rev Endocrinol Metab 11:529\u2013541. https:\/\/doi.org\/10.1080\/17446651.2016.1233055","journal-title":"Expert Rev Endocrinol Metab"},{"key":"4978_CR14","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, G\u00f3mez-S\u00e1nchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM, Endocrine Society (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:3266\u20133281. https:\/\/doi.org\/10.1210\/jc.2008-0104","journal-title":"J Clin Endocrinol Metab"},{"key":"4978_CR15","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","volume":"78","author":"MG Tektonidou","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, D\u00f6rner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78:1296\u20131304. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"},{"key":"4978_CR16","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/j.1538-7836.2006.02193.x","volume":"4","author":"MJ Cuadrado","year":"2006","unstructured":"Cuadrado MJ, Buend\u00eda P, Velasco F, Aguirre MA, Barbarroja N, Torres LA, Khamashta M, L\u00f3pez-Pedrera C (2006) Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome. J Thromb Haemost 4:2461\u20132469. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02193.x","journal-title":"J Thromb Haemost"},{"key":"4978_CR17","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.thromres.2011.11.048","volume":"130","author":"Y Motoki","year":"2012","unstructured":"Motoki Y, Nojima J, Yanagihara M, Tsuneoka H, Matsui T, Yamamoto M, Ichihara K (2012) Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells. Thromb Res 130:667\u2013673. https:\/\/doi.org\/10.1016\/j.thromres.2011.11.048","journal-title":"Thromb Res"},{"key":"4978_CR18","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1182\/blood-2008-12-190629","volume":"114","author":"H Nakagawa","year":"2009","unstructured":"Nakagawa H, Yasuda S, Matsuura E, Kobayashi K, Ieko M, Kataoka H, Horita T, Atsumi T, Koike T (2009) Nicked \u03b22-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property. Blood 114:2553\u20132559. https:\/\/doi.org\/10.1182\/blood-2008-12-190629","journal-title":"Blood"},{"key":"4978_CR19","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/j.1538-7836.2008.03000.x","volume":"6","author":"P Yu","year":"2008","unstructured":"Yu P, Passam FH, Yu DM, Denyer G, Krilis SA (2008) Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain. J Thromb Haemost 6:1215\u20131223. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03000.x","journal-title":"J Thromb Haemost"},{"issue":"3","key":"4978_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jaut.2010.06.013","volume":"35","author":"FH Passam","year":"2010","unstructured":"Passam FH, Qi JC, Tanaka K, Matthaei KI, Krilis SA (2010) In vivo modulation of angiogenesis by beta 2 glycoprotein I. J Autoimmun 35(3):232\u2013240. https:\/\/doi.org\/10.1016\/j.jaut.2010.06.013","journal-title":"J Autoimmun"},{"key":"4978_CR21","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1016\/j.ajpath.2014.07.027","volume":"184","author":"YY Wu","year":"2014","unstructured":"Wu YY, Nguyen A, Wu XX et al (2014) Antiphospholipid antibodies promote tissue factor-dependent angiogenic switch and tumor progression. Am J Pathol 184:3359\u20133375. https:\/\/doi.org\/10.1016\/j.ajpath.2014.07.027","journal-title":"Am J Pathol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04978-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-020-04978-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04978-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:53:07Z","timestamp":1615078387000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-020-04978-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,7]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4978"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-04978-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2020,3,7]]},"assertion":[{"value":"27 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors certify that they obtained the patient\u2019s consent for the use of his images and other clinical information reported in the manuscript. The patient understands that his name and initials will not be published, and due efforts will be made to conceal his identity.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of patient consent"}}]}}